Lantheus Holdings, INC 8-K filings

NASDAQ

26 Jan 2024

LNTH

8-K: Lantheus Faces Patent Infringement Lawsuit Over Generic Cancer Drug

Lantheus Holdings is being sued by Novartis for patent infringement related to its generic version of the cancer drug LUTATHERA.

NASDAQ

23 Jan 2024

LNTH

Lantheus Holdings, INC

8-K: Lantheus Announces CEO Succession Plan: Brian Markison to Take Helm as Mary Anne Heino Transitions to Board Chair

Lantheus Holdings, Inc. has announced a leadership transition, with Brian Markison appointed as CEO effective March 1, 2024, and Mary Anne Heino becoming Chair of the Board.